Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket Submissions

June 17, 2022

Guidance Document

Guidance for Industry and Food and Drug Administration Staff

JUNE 2022

This guidance document provides FDA's recommendations on the information, technical performance assessment, and user information that should be included in a premarket submission for radiological devices that include quantitative imaging functions. The recommendations reflect current review practices and are intended to promote consistency and facilitate efficient review of premarket submissions for radiological devices that include quantitative imaging functions.

Download the FINAL Guidance Document

FINAL

Read the Federal Register Notice

Interested in learning more? Contact us today to find out how we can help not only with your EMA/FDA submissions, but all of your global regulatory needs.

TAGS:

October 8, 2015

FDA Takes Steps to Make REMS Info Easier to Share

FDA is launching a pilot project to integrate Risk Evaluation and Mitigation Strategies (REMS) into Structured Product Label (SPL) format. This will facilitate the sharing of documents and ease the...

October 13, 2015

Can Consumers Handle More Quantitative Info in TV Ads? FDA Plans to Find Out…

FDA wants to know how much of the information presented in television advertisements consumers understandGem, and how much more information they could handle. In an effort to answer these questions,...

March 26, 2018

First Clinical Study Report Data Published for FDA Pilot Project

On Monday, March 19th, the FDA officially began a new Clinical Data Summary Pilot Program. This program is intended to “assess the feasibility of using a different format to provide required...